
The US Federal Reserve has increased benchmark borrowing costs by 0.75% for the second time in a row, in the latest sign of the stronger measures being taken by central banks to try and tame runaway inflation.
Lloyds Banking Group and drugs giant GSK have raised their 2022 guidance after publishing robust half-year results today.